NHLBI Concept to Clinic: Commercializing Innovation (C3i) Program Application Due
Deadline: June 30, 2017 02:00 PM
Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp) - PA-17-286
Effective immediately, The National Heart, Lung, and Blood Institute (NHLBI) is participating in PA-17-286. Applications due by Friday, June 30, 2017 at 5:00PM ET.
The administrative supplement is to provide support for NIH-funded investigators to participate in an entrepreneurship training course, the Concept to Clinic: Commercializing Innovation (C3i) Program. The C3i Program is designed to provide medical device innovators with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic).
Through this program, the NIH fosters the development and commercialization of early-stage biomedical technologies by engaging investigators who are interested in better understanding the value of their innovation in addressing an unmet market need. The curriculum and customized mentoring provided by the C3i Program are intended to guide investigators as they assess the commercial viability and potential business opportunity for their innovation.
For more information about the program before applying, please read the full Funding Opportunity Announcement PA-17-286 and contact:
Kurt Marek, PhD
National Heart, Lung, and Blood Institute (NHLBI)